Role of Hepatocyte TLR4 in Alcohol-induced Steatohepatitis and Insulin Resistance

肝细胞TLR4在酒精性脂肪性肝炎和胰岛素抵抗中的作用

基本信息

  • 批准号:
    10294073
  • 负责人:
  • 金额:
    $ 14.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-01 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Abstract Excessive alcohol drinking-induced chronic liver disease has been recognized as a serious health problem in the United States. Increasing evidence suggests that inflammation plays an essential role in the development of alcoholic liver disease (ALD). In particular, the potent inflammatory response produced by the interactions between gut-derived lipopolysaccharide (LPS) and its cell surface receptor, Toll-like receptor 4 (TLR4), greatly contribute to alcohol-induced liver injury. However, the exact TLR4-expressing cell type that mediates this effect is largely unknown. Recently, we and others reported that hepatocyte TLR4 regulates obesity-related chronic inflammation, insulin resistance, and nonalcoholic liver disease. Furthermore, our preliminary data showed that mice lacking hepatocyte TLR4 had attenuated alcohol-induced early liver injury and reduced inflammation in white adipose tissue. In contrast, mice with TLR4 reactivation in hepatocyte accumulated more triglyceride content in the liver after chronic alcohol drinking. These findings support the potential role of hepatocyte TLR4 in mediating alcohol-induced steatohepatitis and insulin resistance. We will take advantage of our two unique mouse models that can selectively ablate and reactivate TLR4 expression in hepatocytes, respectively, to pursue the following specific aims. In specific aim 1, we will determine the role of hepatocyte TLR4 in the development of alcoholic steatohepatitis. We will use the mice lacking TLR4 expression specifically in hepatocyte to test the hypothesis that hepatocyte TLR4 is required for the development of alcoholic steatohepatitis induced by acute-on-chronic ethanol drinking. In specific aim 2, we will feed mice an ethanol-containing liquid diet chronically up to 8 weeks. We will test the hypothesis that hepatocyte TLR4 is required for the development of alcohol-induced insulin resistance. In specific aim 3, we will use a TLR4 reactivatable mouse model that can restore endogenous TLR4 expression specifically in hepatocytes to determine the sufficiency of hepatocyte TLR4 in alcohol-related steatohepatitis and insulin resistance. These studies will greatly enhance our knowledge of the regulatory role of hepatocyte TLR4 in alcoholic liver damage and associated metabolic disorders and facilitate the development of new anti-ALD therapies.
抽象的 过量饮酒引起的慢性肝病已被认为是一个严重的健康问题 在美国。越来越多的证据表明炎症在 酒精性肝病(ALD)的发展。特别是,由以下物质产生的强烈炎症反应: 肠源性脂多糖 (LPS) 与其细胞表面受体 Toll 样受体 4 之间的相互作用 (TLR4),极大地促进酒精引起的肝损伤。然而,确切的 TLR4 表达细胞类型 介导这种效应很大程度上是未知的。最近,我们和其他人报道了肝细胞 TLR4 调节 肥胖相关的慢性炎症、胰岛素抵抗和非酒精性肝病。此外,我们的 初步数据显示,缺乏肝细胞TLR4的小鼠可以减轻酒精引起的早期肝损伤 并减少白色脂肪组织的炎症。相比之下,肝细胞中TLR4重新激活的小鼠 长期饮酒后,肝脏中会积累更多的甘油三酯含量。这些发现支持 肝细胞 TLR4 在介导酒精诱导的脂肪性肝炎和胰岛素抵抗中的潜在作用。我们将 利用我们的两种独特的小鼠模型,可以选择性地消除和重新激活 TLR4 表达 肝细胞分别追求以下特定目标。在具体目标1中,我们将确定以下角色: 肝细胞 TLR4 在酒精性脂肪性肝炎发展中的作用。我们将使用缺乏 TLR4 的小鼠 特异地在肝细胞中表达,以检验肝细胞 TLR4 是 长期饮酒引起急性酒精性脂肪性肝炎。在具体目标 2 中,我们 将为小鼠长期喂食含乙醇的液体饮食长达 8 周。我们将检验以下假设: 酒精诱导的胰岛素抵抗的发生需要肝细胞 TLR4。在具体目标 3 中,我们 将使用 TLR4 可重新激活的小鼠模型,该模型可以恢复内源性 TLR4 表达,特别是在 肝细胞以确定酒精相关性脂肪性肝炎和胰岛素中肝细胞 TLR4 的充足性 反抗。这些研究将极大地增强我们对肝细胞TLR4在肝细胞中的调节作用的认识。 酒精性肝损伤和相关代谢紊乱,并促进新的抗 ALD 药物的开发 疗法。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lin Jia其他文献

Lin Jia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lin Jia', 18)}}的其他基金

Role of Dietary Cholesterol in Alcoholic Steatohepatitis and Insulin Resistance
膳食胆固醇在酒精性脂肪性肝炎和胰岛素抵抗中的作用
  • 批准号:
    10040154
  • 财政年份:
    2021
  • 资助金额:
    $ 14.95万
  • 项目类别:
Role of Dietary Cholesterol in Alcoholic Steatohepatitis and Insulin Resistance
膳食胆固醇在酒精性脂肪性肝炎和胰岛素抵抗中的作用
  • 批准号:
    10450627
  • 财政年份:
    2021
  • 资助金额:
    $ 14.95万
  • 项目类别:
Role of Hepatocyte TLR4 in Alcohol-induced Steatohepatitis and Insulin Resistance
肝细胞TLR4在酒精性脂肪性肝炎和胰岛素抵抗中的作用
  • 批准号:
    9243504
  • 财政年份:
    2017
  • 资助金额:
    $ 14.95万
  • 项目类别:

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
Defining the role of G6pc-high hepatocyte and Slc25a44 in metabolism via spatial transcriptome
通过空间转录组定义 G6pc-high 肝细胞和 Slc25a44 在代谢中的作用
  • 批准号:
    22KK0271
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease
原代肝细胞和工程 iPSC 衍生的肝细胞样细胞移植治疗 α-1 抗胰蛋白酶缺乏相关的肝病
  • 批准号:
    10607039
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
Development of a Microphysiological System for Transvascular Drug Delivery to 3D Hepatocyte Spheroids
开发用于 3D 肝细胞球体经血管药物输送的微生理系统
  • 批准号:
    23K19214
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH
确定 Ube4A 调节 NAFLD/NASH 的肝细胞特异性机制
  • 批准号:
    10587876
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
Integrative analysis of metabolomics transcriptomics and proteomics to study mechanisms that regulate lentiviral vector hepatocyte transduction
代谢组学、转录组学和蛋白质组学的综合分析,研究调节慢病毒载体肝细胞转导的机制
  • 批准号:
    BB/Y513532/1
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
    Training Grant
Integrative analysis of metabolomics, transcriptomics and proteomics to study mechanisms that regulate lentiviral vector hepatocyte transduction
代谢组学、转录组学和蛋白质组学的综合分析,研究慢病毒载体肝细胞转导的调节机制
  • 批准号:
    2891574
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
    Studentship
Characterizing zonated hepatocyte sexual dimorphism and its role in fatty liver disease
分区肝细胞性别二态性的特征及其在脂肪肝疾病中的作用
  • 批准号:
    10588098
  • 财政年份:
    2023
  • 资助金额:
    $ 14.95万
  • 项目类别:
Roles of the Lysine Methyl Transferase (KMT) 2D in hepatocyte cell identity and hepatocellular carcinoma (HCC) progression
赖氨酸甲基转移酶 (KMT) 2D 在肝细胞细胞识别和肝细胞癌 (HCC) 进展中的作用
  • 批准号:
    472010
  • 财政年份:
    2022
  • 资助金额:
    $ 14.95万
  • 项目类别:
    Fellowship Programs
The role of hepatocyte tPA in hepatic VLDL production.
肝细胞 tPA 在肝 VLDL 产生中的作用。
  • 批准号:
    10420269
  • 财政年份:
    2022
  • 资助金额:
    $ 14.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了